PT Indofarma Tbk (ISX:INAF) EBIT per Share : Rp-159.04 (TTM As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk EBIT per Share?

PT Indofarma Tbk's EBIT per Share for the three months ended in Sep. 2023 was Rp-21.63. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was Rp-159.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PT Indofarma Tbk's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PT Indofarma Tbk was 24.60% per year. The lowest was -46.90% per year. And the median was -0.75% per year.

ISX:INAF's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PT Indofarma Tbk's EBIT for the three months ended in Sep. 2023 was Rp-67,048 Mil.

PT Indofarma Tbk EBIT per Share Historical Data

The historical data trend for PT Indofarma Tbk's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk EBIT per Share Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

7.28

15.01

20.43

16.69

-154.71

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT per Share	Get a 7-Day Free Trial															-27.68	-103.04	-16.75	-17.61	-21.63

PT Indofarma Tbk EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PT Indofarma Tbk's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-479476.871	/	3099.268
=	-154.71

PT Indofarma Tbk's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-67047.703	/	3099.268
=	-21.63

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-159.04

PT Indofarma Tbk (ISX:INAF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PT Indofarma Tbk EBIT per Share Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines